Poveda E - Search Results

1

Late HIV Diagnosis but Earlier Antiretroviral Treatment Initiation in Northwest Spain: Impact of Current Treatment Guidelines.

Cid-Silva P, Margusino-Framiñán L, Balboa-Barreiro V, Pernas-Souto B, Mena-De-Cea Á, Martín-Herranz I, Castro-Iglesias Á, Poveda E. Cid-Silva P, et al. Among authors: poveda e. J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218821940. doi: 10.1177/2325958218821940. J Int Assoc Provid AIDS Care. 2019. PMID: 30798655 Free PMC article.

2

Impact of antiretroviral therapy on chemokine (C-C motif) receptor 5 expression in HIV patients followed for over 2 years.

Briz V, Poveda E, López M, González Mdel M, Soriano V, Benito JM. Briz V, et al. Among authors: poveda e. AIDS. 2008 Jul 11;22(11):1371-4. doi: 10.1097/QAD.0b013e3283018504. AIDS. 2008. PMID: 18580618

3

Multi-step inhibition against HIV lifecycle-underlying the "magic" of protease inhibitors.

Poveda E. Poveda E. AIDS Rev. 2014 Jan-Mar;16(1):52. AIDS Rev. 2014. PMID: 24589971 No abstract available.

4

HIV-2 viral tropism influences CD4+ T cell count regardless of viral load.

Treviño A, Soriano V, Poveda E, Parra P, Cabezas T, Caballero E, Roc L, Rodríguez C, Eiros JM, Lopez M, De Mendoza C; HIV-2 Spanish Study Group. Treviño A, et al. Among authors: poveda e. J Antimicrob Chemother. 2014 Aug;69(8):2191-4. doi: 10.1093/jac/dku119. Epub 2014 Apr 30. J Antimicrob Chemother. 2014. PMID: 24788659

5

High prevalence of subtype F in newly diagnosed HIV-1 persons in northwest Spain and evidence for impaired treatment response.

Pernas B, Grandal M, Mena A, Castro-Iglesias A, Cañizares A, Wyles DL, López-Calvo S, Pértega S, Rodríguez-Osorio I, Pedreira JD, Poveda E. Pernas B, et al. Among authors: poveda e. AIDS. 2014 Jul 31;28(12):1837-40. doi: 10.1097/QAD.0000000000000326. AIDS. 2014. PMID: 24871456

6

Update on hepatitis C virus resistance to direct-acting antiviral agents.

Poveda E, Wyles DL, Mena A, Pedreira JD, Castro-Iglesias A, Cachay E. Poveda E, et al. Antiviral Res. 2014 Aug;108:181-91. doi: 10.1016/j.antiviral.2014.05.015. Epub 2014 Jun 6. Antiviral Res. 2014. PMID: 24911972 Review.

7

Highlights from CROI 2014 on experimental HIV drugs.

Poveda E, Pedreira JD. Poveda E, et al. AIDS Rev. 2014 Apr-Jun;16(2):118. AIDS Rev. 2014. PMID: 24984767 No abstract available.

8

Ingenol derivates promising for HIV eradication.

Poveda E. Poveda E. AIDS Rev. 2014 Oct-Dec;16(4):246. AIDS Rev. 2014. PMID: 25373349

9

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing.

Mena A, Moldes L, Meijide H, Cañizares A, Castro-Iglesias A, Delgado M, Pértega S, Pedreira J, Bou G, Poveda E. Mena A, et al. Among authors: poveda e. PLoS One. 2014 Dec 1;9(12):e113062. doi: 10.1371/journal.pone.0113062. eCollection 2014. PLoS One. 2014. PMID: 25436642 Free PMC article.

10

Molecular characterization of HIV-1 infection in Northwest Spain (2009-2013): Investigation of the subtype F outbreak.

Paraskevis D, Kostaki E, Beloukas A, Cañizares A, Aguilera A, Rodríguez J, Grandal M, Pernas B, Castro-Iglesias A, Mena Á, Pedreira JD, Poveda E. Paraskevis D, et al. Among authors: poveda e. Infect Genet Evol. 2015 Mar;30:96-101. doi: 10.1016/j.meegid.2014.12.012. Epub 2014 Dec 16. Infect Genet Evol. 2015. PMID: 25527396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page